CVSG
+0.0 · +0.00%
GBX · LSE

CVS Group Plc(CVSG) Stock Analysis | Healthcare

GBX --+0.00%
Reward51Moderate
Risk50Moderate
75%Data
Deep Value
Market Cap:895.07M
ⓘ
Reward Rating
51
Moderate
Reward Assessment
75% data coverage
Bottom 50% of stocksView factors
ⓘ
Risk Rating
50
Moderate
Risk Assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on CVSG to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is CVS Group Plc?

CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia.

AI Brief Pro

The brief on CVS Group Plc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is CVS Group Plc?

CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 895.07M, and a P/E ratio of 57.2x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (51)

Similar stocks to compare

A short list of Medical Care Facilities names that are close enough in size to make side-by-side comparison useful.

All Healthcare stocks →
Company Information
IndustryMedical Care Facilities
Market Cap895.07M
P/E Ratio57.2174
Beta1.071
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.